Prime Medicine, Inc. ( PRME) - Key Metrics
PRME Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.24 | -$0.23 | -$0.23 |
| 2026Q1 | $0 | -$0.28 | -$0.24 | -$0.24 |
| 2025Q4 | $0.01 | -$0.31 | -$0.25 | -$0.25 |
| 2025Q3 | $0.01 | -$0.32 | -$0.22 | -$0.22 |
| 2025Q2 | $0.01 | -$0.41 | -$0.32 | -$0.33 |
PRME Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.84 |
| 2026Q1 | 0% | -3.11 |
| 2025Q4 | 0% | -3.34 |
| 2025Q3 | 0% | -4.33 |
| 2025Q2 | 0% | -1.52 |
PRME
Price: $3.24
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 580.4 million